Drug Formulary Review articles from January 2007

Drug Formulary Review archives from January 2007

Analyzing reasons for ICU adverse drug events: Look beyond cost and frequency of use.
January 1, 2007... Analyzing reasons for ICU adverse drug events: Look beyond cost and frequency of use The frequency, severity, and preventability of adverse drug events (ADEs) in intensive care units (ICUs) are not associated with a drug's cost or...

Appropriate antibiotics needed for VAP management.
January 1, 2007... Appropriate antibiotics needed for VAP management Clinicians who manage ventilator-associated pneumonia (VAP) patients should promote appropriate use of antibiotics to optimize patients' outcomes and prevent antibiotic resistance. That's...

Pharmacist-managed clinics succeed.
January 1, 2007... Pharmacist-managed clinics succeed Pharmacist-managed diabetes care clinics achieve high screening rates and attain treatment goals more often than national averages, according to two separate studies published in the American Journal of...

News Brief: Special considerations for bariatric surgery patients.
January 1, 2007... Special considerations for bariatric surgery patients Patients who have undergone bariatric surgery should take steps to be sure they are absorbing their medications and nutrients, according to University of Kentucky researchers writing in...

Drug Criteria & Outcomes: Oxymorphone (Opana[R]) Formulary Evaluation.
January 1, 2007... Drug Criteria & Outcomes Oxymorphone (Opana®) Formulary Evaluation Part 1: Indications, Mechanism of Action, Pharmacokinetics, Contraindications, and Adverse Effects By Erica Oelfke, PharmD Candidate, Auburn (AL) University ...

Drug Criteria & Outcomes: New FDA Approvals.
January 1, 2007... Drug Criteria & Outcomes FDA recently approved these drugs: • QLT USA's metronidiazole vaginal gel, 0.75%, the first generic version of 3M's MetroGel-Vaginal was approved for treating bacterial vaginosis. FDA said QLT callenged...

CE objectives/questions.
January 1, 2007... CE objectives/questions This CE program will improve participants' ability to: *Compare the clinical efficacy and safety of one therapeutic agent over another used in the same setting. *Assess clinical trial data and explain how...